Powder: -20°C for 3 years
In solvent: -80°C for 2 years
Bulevirtide (Myrcludex B) acetate is a virion entry inhibitor which blocks the virion's hepatocyte pathway of entry, the hepatic sodium/taurocholate cotransporting polypeptide (NTCP) receptor. Bulevirtide (Myrcludex B) acetate can be used in <a href="/target/HBV" style="display: inline; color: #c13a36">HBV</a> and HDV infection studies.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 197.00 | |
5 mg | In stock | $ 419.00 | |
10 mg | In stock | $ 667.00 | |
25 mg | In stock | $ 1,277.00 | |
50 mg | In stock | $ 1,919.00 | |
100 mg | In stock | $ 2,872.00 |
Description | Bulevirtide (Myrcludex B) acetate is a virion entry inhibitor which blocks the virion's hepatocyte pathway of entry, the hepatic sodium/taurocholate cotransporting polypeptide (NTCP) receptor. Bulevirtide (Myrcludex B) acetate can be used in HBV and HDV infection studies. |
Molecular Weight | 5458.91 |
Formula | C236H333N65O73 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
H2O: Insoluble
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Bulevirtide (Myrcludex B) acetate Microbiology/Virology HBV Inhibitor inhibitor inhibit